GSK to Acquire Boston biopharmaceutical company IDRx for up to $1.15 billion
GSK expands its cancer treatment pipeline by acquiring IDRx, enhancing its focus on gastrointestinal oncology with cutting-edge therapies.
GSK expands its cancer treatment pipeline by acquiring IDRx, enhancing its focus on gastrointestinal oncology with cutting-edge therapies.
Artá Capital invests in Viokox, a leading cosmetics firm in Spain, to boost global expansion, R&D, and market presence with…
De Cecco wins the "Industria Felix" award for the 5th year, recognized for financial stability, sustainability, and top management in…
Alexander Sagel named CEO of Renk Group, effective Feb 2025, leading innovation in the defense sector after strong Q3 revenue…
Luxury footwear hub FTC consolidates top Tuscan companies to boost efficiency and preserve artisanal expertise in the global market.
Crypto.com acquires Fintek Securities, gaining an Australian financial license to expand its crypto and CFD services under ASIC regulations.
Apple has developed a thoughtful strategy to handle leadership transitions, focusing on maintaining stability during the departure of key executives.…
Nvidia surpasses Microsoft as the world's top company, with a $3.335 trillion market cap, driven by high GPU demand for…
Luxy is a prime example of the recent evolution seen in many Italian companies that balance tradition with innovation. The…
Valeo Foods Group acquires Dal Colle, expanding its Italian platform with high-quality bakery products like Pandori, Panettoni, and Croissants.